KYMR

Kymera Therapeutics Inc (KYMR)

US
$ 44.360.29%

Price Chart

Key Statistics

Market Cap
$ 1.95B
P/E Ratio
0.00
Revenue (TTM)
$ 58.89M
Volume
907.31K
52W High
$ 53.27
52W Low
$ 19.45
Dividend Yield
0.00%
Beta
2.19

Technicals

50-Day MA
29.9741
200-Day MA
40.0899
52 Week High
53.27
52 Week Low
19.445

About KYMR

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing.

Employees
208
Headquarters
Watertown, MA
CEO
Dr. Bruce L. Booth DPHIL, Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg